Carregant...
Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is a chronic and disabling condition characterized by recurrent thrombosis and miscarriages mediated by antibodies against phospholipid-binding proteins (aPL), such as beta(2)glycoprotein I (β(2)GPI). Complement is involved in APS animal models and complement deposits...
Guardat en:
Publicat a: | Front Immunol |
---|---|
Autors principals: | , , , , , , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Frontiers Media S.A.
2019
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6474283/ https://ncbi.nlm.nih.gov/pubmed/31031764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00773 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|